ArticleBMC nephrology2025
End-stage kidney disease patients during the current Gaza war: challenges and outcomes of care.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Disasters and hazard exposure in end-stage kidney disease: a scoping review of patient outcomes.Clinical kidney journal · 2026Article
- Disaster Management in Hemodialysis Centers: Ensuring Continuity of Lifesaving Care.Avicenna journal of medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aims to investigate the challenges and complications faced by End-Stage kidney Disease (ESKD) patients undergoing dialysis during the Gaza conflict.
methodsA cross-sectional study was conducted on 105 ESKD patients undergoing dialysis. Data were collected through a customized, interviewer-administered questionnaire at a single center, Al Aqsa Hospital in central Gaza (from October to November 2024). Statistical analysis was performed using SPSS software.
resultsThe mean age of participants was 49.9 years. 47.6% were male, resided in Deir Al Balah, lived in tents, and were displaced. Additionally, most patients faced difficulties accessing hospitals (70.5%), while 94.3% were unaffected by war-related injuries. Regarding dialysis, 73.3% of participants initially received three dialysis sessions per week, but this decreased to 68.6%. In terms of challenges, 81% reported damage to dialysis machines, 91.4% were affected by electricity cuts, 63.8% experienced gaps in dialysis due to displacement, and 33.3% cited a shortage of medical staff. With respect to diet and medications, 43.8% reported adherence, 54.3% faced difficulties obtaining their medications, 49.5% had lost their prior medical records, and 80% carried a list of their current medications. The most frequently reported complications included intradialytic hypotension (61.9%), hospitalization during dialysis (52.4%), and weight loss (70.5%). Our analysis revealed a statistically significant association between interruptions in dialysis therapy and hospitalization rates (p < 0.001). Additionally, displaced patients had a significantly higher loss of medical records compared to non-displaced patients (p = 0.014). A significant difference was also observed in dialysis session length changes in relation to hospitalization (p = 0.018). Logistic regression showed that patients with comorbidities were 2.5 times more likely to develop complications. However, this result wasn't statistically significant (p = 0.058).
conclusionThis study highlights the challenges faced by ESKD patients during the Gaza conflict and their associated complications. International support is crucial to protecting ESKD patients in conflict zones. Telemedicine and patient education may help mitigate complications. Further studies are needed to improve the care of ESKD patients in conflict-affected areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.